Cari
Produk
Komunitas
Pasar
Berita
Broker
Lebih lanjut
ID
Mulai
Komunitas
/
Ide-Ide
/
$IDXG On The Run Again and this time it will be sustained
Pembelian
$IDXG On The Run Again and this time it will be sustained
Oleh StockGuild
Ikuti
Ikuti
Diupdate
29 Mar 2017
6
29 Mar 2017
Let's recap
IDXG
CC:
1. New York State and AETNA approvals of ThyraMIR®, microRNA assay
2. Talked about the Debt being restructured
3. No more offerings
4. Reduced operating costs
5. Talks of doing business with their BarreGen model
6. Talks of partnering with another bio he didn't discuss.
7. EPS value of $3.25 vs -($12.04) same quarter last year
8. Sales of $3.122 million.
9. Goldman, Rodman and Renshaw, Barclays were on the CC too big boys will be here soon enough count on it.
10. 64% of the S/S is SHORT
11. Raised $14 million in gross equity and restructured over $9.3 million of secured debt
12. Revenue increased 39%
Also most importantly the Patent Approval!!!
IDXG
European Patent Decision
data.epo.org/publication-server/pdf-document?pn=2772550&ki=B1&cc=EP
ALSO FULL YEAR HIGHLIGHTS READ HERE:
ih.advfn.com/p.php?pid=nmona&article=74215692
29 Mar 2017
Catatan
Alerted this on Twitter earlier in the day. Will post charts in real time next time.
BAC
breakout
Facebook (FB)
FNMA
Fundamental Analysis
IDXG
microcap
snap
technicals
TWTR
StockGuild
Ikuti
Juga di:
Pernyataan Penyangkalan
Informasi dan publikasi tidak dimaksudkan untuk menjadi, dan bukan merupakan saran keuangan, investasi, perdagangan, atau rekomendasi lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di
Persyaratan Penggunaan
.